Apexium Financial’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.7M Sell
41,751
-375
-0.9% -$32.4K 0.18% 64
2025
Q2
$3.63M Sell
42,126
-307
-0.7% -$26.4K 0.19% 62
2025
Q1
$3.87M Buy
42,433
+833
+2% +$75.7K 0.23% 53
2024
Q4
$3.58M Buy
41,600
+220
+0.5% +$20.3K 0.22% 52
2024
Q3
$4.06M Sell
41,380
-320
-0.8% -$31K 0.27% 42
2024
Q2
$3.87M Sell
41,700
-798
-2% -$72.8K 0.28% 42
2024
Q1
$3.96M Buy
42,498
+367
+0.9% +$33.2K 0.3% 41
2023
Q4
$3.65M Sell
42,131
-379
-0.9% -$31.4K 0.26% 51
2023
Q3
$3.5M Buy
42,510
+125
+0.3% +$10.6K 0.35% 39
2023
Q2
$3.6M Sell
42,385
-4,064
-9% -$347K 0.32% 38
2023
Q1
$3.87M Sell
46,449
-455
-1% -$37.7K 0.38% 36
2022
Q4
$3.98M Sell
46,904
-265
-0.6% -$21.9K 0.41% 31
2022
Q3
$3.55M Buy
+47,169
New +$3.82M 0.44% 31

Other funds holding IXJ

Apexium Financial's IXJ Position: Q3 2025 in Review

Apexium Financial reduced its iShares Global Healthcare ETF (IXJ) stake by 0.89% in Q3 2025, selling an estimated $32.4K and leaving 41,751 shares worth $3.7M. The position accounts for 0.18% of the portfolio, ranked #64.

Apexium Financial first reported a position in IXJ in Q3 2022 and has held it in 13 quarters since. The position peaked at $4.06M in Q3 2024. 257 funds tracked by Wall St. Rank hold IXJ as of Q3 2025.

  • Apexium Financial held 41,751 shares of iShares Global Healthcare ETF worth $3.7M as of Q3 2025.
  • Apexium Financial sold 375 iShares Global Healthcare ETF shares in Q3 2025, an estimated $32.4K.
  • iShares Global Healthcare ETF made up 0.18% of Apexium Financial's portfolio in Q3 2025, its #64 holding.
  • Apexium Financial first reported a position in iShares Global Healthcare ETF in Q3 2022 and has held it in 13 quarters since.
  • Apexium Financial's iShares Global Healthcare ETF position peaked at $4.06M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.